Gini Fleming to Hereditary Breast and Ovarian Cancer Syndrome
This is a "connection" page, showing publications Gini Fleming has written about Hereditary Breast and Ovarian Cancer Syndrome.
Connection Strength
0.403
-
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial. Gynecol Oncol. 2022 02; 164(2):278-287.
Score: 0.202
-
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study. Gynecol Oncol. 2022 02; 164(2):245-253.
Score: 0.202